KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Deferred Taxes: 2009-2024

Historic Deferred Taxes for Chemed (CHE) over the last 16 years, with FY2024 value amounting to -$4.1 million.

  • Chemed's Deferred Taxes fell 182342.86% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.4 million, marking a year-over-year decrease of 29693.49%. This contributed to the annual value of -$4.1 million for FY2024, which is 4844.9% up from last year.
  • Per Chemed's latest filing, its Deferred Taxes stood at -$4.1 million for FY2024, which was up 4844.9% from -$8.0 million recorded in FY2023.
  • Chemed's 5-year Deferred Taxes high stood at $14.8 million for FY2022, and its period low was -$8.0 million during FY2023.
  • Moreover, its 5-year median value for Deferred Taxes was $1.4 million (2020), whereas its average is $1.3 million.
  • In the last 5 years, Chemed's Deferred Taxes soared by 51779.17% in 2022 and then tumbled by 15413.77% in 2023.
  • Chemed's Deferred Taxes (Annual) stood at $1.4 million in 2020, then skyrocketed by 67.48% to $2.4 million in 2021, then soared by 517.79% to $14.8 million in 2022, then crashed by 154.14% to -$8.0 million in 2023, then skyrocketed by 48.45% to -$4.1 million in 2024.
  • Its last three reported values are -$4.1 million in FY2024, -$8.0 million for FY2023, and $14.8 million during FY2022.